Improved synthesis of fenofibrate as lipid-lowering drug

被引:0
|
作者
Man, Lili [1 ]
Li, Shuliang [2 ]
Yang, Hanyue [2 ]
Yan, Xianguang [2 ]
Dong, Shubo [2 ]
Zhang, Zhenming [3 ]
机构
[1] School of Pharmacy, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
[2] Jiangsu Deyuan Pharmaceutical Co., Ltd., Jiangsu, Lianyungang,222047, China
[3] School of Environmental and Chemical Engineering, Jiangsu Ocean University, Jiangsu, Lianyungang,222005, China
来源
Jingxi Huagong/Fine Chemicals | 2023年 / 40卷 / 07期
关键词
D O I
10.13550/j.jxhg.20220880
中图分类号
学科分类号
摘要
22
引用
收藏
页码:1505 / 1512
相关论文
共 50 条
  • [21] METABOLIC STUDIES WITH PROBUCOL - A NEW LIPID-LOWERING DRUG
    SIMONS, LA
    BALASUBRAMANIUM, S
    BEINS, D
    ROWE, M
    RUYS, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (04): : 472 - 472
  • [22] LIFIBROL - A NOVEL LIPID-LOWERING DRUG FOR THE THERAPY OF HYPERCHOLESTEROLEMIA
    LOCKER, PK
    JUNGBLUTH, GL
    FRANCOM, SF
    HUGHES, GS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (01) : 73 - 88
  • [23] Primary prevention lipid-lowering drug therapy - Response
    Gotto, AM
    Kuller, LH
    CIRCULATION, 2002, 106 (07) : E35 - E36
  • [24] The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia
    Saklamaz, A
    Comlekci, A
    Temiz, A
    Caliskan, S
    Ceylan, C
    Alacacioglu, A
    Yesil, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (05): : 677 - 681
  • [26] Lipid-Lowering Drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1506): : 133 - 140
  • [27] Lipid-lowering drugs
    K. Pahan
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1165 - 1178
  • [28] LIPID-LOWERING DRUGS
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1980, 22 (16): : 65 - 66
  • [29] Lipid-Lowering Drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1659): : 145 - +
  • [30] Lipid-Lowering Drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1565): : 17 - 24